PALISADE CAPITAL MANAGEMENT, LP - NOVAVAX INC ownership

NOVAVAX INC's ticker is and the CUSIP is 670002AB0. A total of 26 filers reported holding NOVAVAX INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of NOVAVAX INC
ValueSharesWeighting
Q4 2022$8,433,620
+34.3%
8,476,000
+32.9%
0.23%
+27.5%
Q3 2022$6,280,000
+23.5%
6,376,000
+25.3%
0.18%
+29.0%
Q2 2022$5,085,000
+709.7%
5,089,000
+408.9%
0.14%
+500.0%
Q4 2018$628,000
+3.0%
1,000,0000.0%0.02%
+35.3%
Q3 2018$610,000
+2.9%
1,000,0000.0%0.02%0.0%
Q2 2018$593,000
-16.5%
1,000,0000.0%0.02%
-29.2%
Q1 2018$710,000
+48.8%
1,000,0000.0%0.02%
+50.0%
Q4 2017$477,000
+1.3%
1,000,0000.0%0.02%
-5.9%
Q3 2017$471,000
-26.7%
1,000,000
-33.3%
0.02%
-29.2%
Q2 2017$643,000
-5.9%
1,500,0000.0%0.02%
-7.7%
Q1 2017$683,0001,500,0000.03%
Other shareholders
NOVAVAX INC shareholders Q4 2022
NameSharesValueWeighting ↓
Graham Capital Management, L.P. 65,636,000$117,228,0006.14%
WHITEBOX ADVISORS LLC 34,014,000$60,630,0001.23%
Saltoro Capital, LP 1,500,000$2,689,0001.09%
DeepCurrents Investment Group LLC 19,500,000$35,011,0001.05%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 25,000,000$44,647,0000.79%
CSS LLC/IL 9,250,000$16,583,0000.69%
WOLVERINE ASSET MANAGEMENT LLC 48,772,000$87,240,0000.66%
SSI INVESTMENT MANAGEMENT LLC 2,914,000$5,198,0000.34%
LINDEN ADVISORS LP 27,403,000$48,980,0000.26%
PFM Health Sciences, LP 4,250,000$7,612,0000.24%
View complete list of NOVAVAX INC shareholders